Hover to zoom
Recovery & StructuralSynthetic research compound
BPC-157 / TB-500 Blend
$89.99
10 mg· 2 strengths availableThis preparation supplies BPC-157 and TB-500 together in a single lyophilized vial. BPC-157 is studied in cellular signaling and vascular-related models; TB-500 is studied for its actin-binding properties and role in cytoskeletal dynamics.
The combination is used in laboratory research where both pathways are of interest within the same experimental condition.
Research areas
Cellular signalingActin and cytoskeletal dynamicsCombined-pathway researchPreclinical research
Form: Lyophilized (freeze-dried)
- Compound class
- Synthetic research compound
- Research category
- Recovery & Structural
- SKU
- NVR-BPC-157-TB-500-BLEND-10MG
- Alternate name
- BPC + TB
- Appearance
- Lyophilized powder
- Storage
- Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Select strength
Cost per mg shown for each option
1
$89.99per 10 mg$9.00/mg
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know
More detail on BPC-157 / TB-500 Blend.
Analytical values reflect per-lot documentation and appear once a batch is released.
Compound
The two components address different aspects of structural cell biology — one associated with signaling and vascular pathways, the other with the actin cytoskeleton — so combining them gives a broad rather than selective probe. That breadth suits exploratory preclinical designs but complicates attribution: separate single-compound conditions are needed to determine which component drives an observed result. Both peptides are widely used in the research literature and both remain mechanistically incompletely defined. This entry, like the others, is sold strictly for that kind of work.
Peptide class
Synthetic research compound
Mechanism (research context)
Extended mechanistic characterization for this compound is available in the published literature. Consult peer-reviewed references for detailed pathway analysis.
Why it is studied
BPC-157 / TB-500 Blend is studied within its research category (Recovery & Structural) as a defined-sequence reference compound for laboratory investigation.
Current areas of research
Cellular signalingActin and cytoskeletal dynamicsCombined-pathway researchPreclinical research
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
Scientific background
BPC-157 / TB-500 Blend is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.
Related
View all →Related research materials
BPC-157 / TB-500 Blend
10 mg · $89.99